Pharmacist prescribing: Review of the literature

Journal of Pharmacy Practice and Research

Volumn 34, Issue 4, 2004, Pages 300-304

  Kay, Olivia C ^a   Brien, Jo Anne E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ECONOMIC ASPECT; OUTCOMES RESEARCH; PHARMACIST; PRESCRIPTION; RESEARCH; REVIEW; UNITED KINGDOM; UNITED STATES;

EID: 13544263334     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr2004344300     Document Type: Review

References (110)

1. Barry CP, Fuller TS. A path to pharmaceutical care (part 2): evolution of collaborative drug therapy management. Hosp Pharm 1998; 33: 490-7.
2. Hammond RW, Schwartz AH, Campbell MJ, Remington TL, Chuck S, Blair MM, et al. Collaborative drug therapy management by pharmacists-2003. Pharmacotherapy 2003; 23: 1210-25.
3. Copeland GP, Apgar DA. The pharmacist practitioner training program. Drug Intell Clin Pharm 1980; 14: 114-9.
4. Report of task force on the pharmacist's clinical role. J Am Pharm Assoc 1971; NS11: 482-5.
5. Carmichael JM, O'Connell MB, Devine B, Kelly HW, Ereshefsky L, Linn WD, et al. Collaborative drug therapy management by pharmacists. Pharmacotherapy 1997; 17: 1050-61.
6. Root G. Pharmacist prescribing. Supplementary prescribing - a groundbreaking opportunity. Pharm J 2003; 270: 19-20.
7. Pearson G, Yuksel N, Card D, Chin T, Gray M, Hawbold J, et al. An information paper on pharmacist prescribing within a health care facility. Can J Hosp Pharm 2002; 55: 56-62.
8. Farrell J, North-Lewis P, Cross M. Pharmacist prescribing in the United States. Pharm J 1997; 259: 187-190.
9. Webb CE. Prescribing medications: changing the paradigm for a changing health care system. Am J Health Syst Pharm 1995; 52: 1693-5.
10. Galt KA. The key to pharmacist prescribing: collaboration. Am J Health Syst Pharm 1995; 52: 1696-9.
11. Carver LK. Pharmacist clinicians-addressing 21 st century health care needs. Pharm Pract Manag Q 1995; 15: 1-8.
12. Crown J. Review of prescribing, supply and administration of medicines. Final report. London: Department of Health, 1999.
13. Child D, Cantrill JA. Hospital doctors' perceived barriers to pharmacist prescribing. Int J Pharm Pract 1999; 7: 230-7.
14. Child D, Hirsch C, Berry M. Health care professionals' views on hospital pharmacist prescribing in the United Kingdom. Int J Pharm Pract 1998; 6: 159-69.
15. Menard PJ, Krishner BS, Kloth DD, Pyka RS, Hill LR, Venkataraman K. Management of the hypertensive patient by the pharmacist prcscriber. Hosp Pharm 1986; 21: 20-33.
16. Thompson JF, McGhan WF, Ruffalo RL, Cohen DA, Adameik B, Segal JL. Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. J Am Geriatr Soc 1984; 32: 154-9.
17. Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy. Am J Hosp Pharm 1992; 49: 387-94.
18. Radley AS, Hall J, Farrow M, Carey PJ. Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic. J Clin Pathol 1995; 48: 545-7.
19. Rosen CE, Holmes S. Pharmacist's impact on chronic psychiatric outpatients in community mental health. Am J Hosp Pharm 1978; 35: 704-8.
20. Cohen IA, Hutchinson TA, Kirking DM, Shuc ME. Evaluation of a pharmacist-managed anticoagulant clinic. J Clin Hosp Pharm 1985; 10: 167-75.
21. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care - anticoagulant control, patient outcomes, and health care costs. Arch Intern Mcd 1998; 158: 1641-7.
22. Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, et al. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm 2002; 59: 1518-26.
23. Stimmel GL, McGhan WF, Wincor MZ, Deandrea DM. Comparison of pharmacist and physician prescribing for psychiatrix inpatients. Am J Hosp Pharm 1982; 39: 1483-6.
24. McGhan WF, Stimmel GL, Hall TG, Gilman TM. A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients. Med Care 1983; 21: 435-44.
25. Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost-justification of a clinical pharmacist-managed anticoagulant clinic. Drug Intell Clin Pharm 1985; 19: 575-80.
26. Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HG. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy 2002; 22: 1294-1300.
27. Davis S. Evaluation of pharmacist management of streptococeal throat infection in a health maintenance organization. Am J Hosp Pharm 1978; 35: 561-6.
28. Garabedian-Ruffalo SM, Gray DR, Saw MJ, Ruffalo RL. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985; 42: 304-8.
29. Hawkins DW, Fiedler FP, Herschel DL, Eschbach RC. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 1979; 36: 1321-5.
30. Chenella FC, Klotz TA, Gill MA, Kern JW, McGhan WF, Paulson YJ, et al. Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. Am J Hosp Pharm 1983; 40: 1642-5.
31. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control - a four-year analysis of an ambulatory care model. Arch Intern Med 1984; 144: 1159-62.
32. Finley PR, Rens HR, Pont JT, Gess SL, Louie C, Bull SA, et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy 2003; 23: 1175-85.
33. Konzem SL, Gray DR, Kashyap ML. Effect of pharmaceutical care on optimum colestipol treatment in elderly hypercholesterolemic veterans. Pharmacotherapy 1997; 17: 576-83.
34. Lee Y, Schommer JC. Effect of a pharmacist-managed anticoagulant clinic on warfarin-related hospital readmissions. Am J Health Syst Pharm 1996; 53: 1580-3.
35. Solomon DK, Portner TS, Bass GE, Gourley DR, Gourley GA, Holt JM, et al. Part 2. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc 1998; 38: 574-85.
36. Pauley TR, Magee MJ, Cury JD. Pharmacist-managed, physician-directed asthma management program reduces emergency department visits. Ann Pharmacother 1995; 29: 5-9.
37. Woolfrey S, Dean C. Hall H. Hospital pharmacist prescribing: a pilot study. Pharm J 2000; 265: 97-9.
38. Hughes DS, Kinnear AE, Macintyre JL, Pacitti L. Collaborative medicines management: pharmacist prescribing. Pharm J 1999; 263: 170-2.
39. Norris CM, Thomas V, Calvert PS. An audit to evaluate the acceptability of a pharmacist electronically prescribing discharge medication and providing information to GPs. Pharm J 2001; 267: 857-9.
40. Anaya JP. Outcomes evaluation of pharmacist-managed diabetes mellitus patients under a collaborative drug therapy agreement [abstract]. Pharmacotherapy 2000; 20: 1266.
41. Martin JE, Begg E. Evaluation of a pharmacist-managed anticoagulation clinic within an accredited ambulatory care pharmacist: pilot study [abstract]. Can J Hosp Pharm 1998; 51: 297.
42. Cooke CE, Mullins CD. Evaluating the economic impact of a pharmacist-managed hypertension program [abstract]. Pharmacotherapy 1999; 19: 523-4.
43. Nesbit SA. Development and implementation of a pharmacist-coordinated cancer pain program [abstract]. Pharmacotherapy 1999; 19: 532.
44. McKenney JM, Slining JM, Henderson HR, Devins D, Barr M. The effect of clinical pharmacy service on patients with essential hypertension. Circulation 1973; 48: 1104-11.
45. Furmaga EM. Pharmacist management of a hyperlipidemia clinic. Am J Hosp Pharm 1993; 50: 91-5.
46. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med 2003; 163: 1813-20.
47. Jay C. The role of the pre-admissions pharmacist. Hosp Pharm 1998; 6: 105-6.
48. Culshaw M, Dawes S. Assessing the value of a discharge pharmacist. Pharm Manage 1998; 14: 22-3.
49. Scrivens JJ, Magalian P, Crozier GA. Cost-effective clinical pharmacy service in a veterans administration drop-in clinic. Am J Hosp Pharm 1983; 43: 1952-3.
50. Hebron B, Jay C. Pharmaceutical care for patients undergoing elective ENT surgery. Pharm J 1998; 260: 65-6.
51. Jones RJ, Goldman MP, Rockwood RP, Imhoff TE. Beneficial effect of a pharmacist refill evaluation clinic. Hosp Pharm 1987; 22: 166-8.
52. Phillips SL, Carr-Lopez SM. Impact of a pharmacist on medication discontinuation in a hospital-based geriatric clinic. Am J Hosp Pharm 1990; 47: 1075-9.
53. Harrison WL, Flinkow SP. Clinical pharmacy in a methadone program. Am J Hosp Pharm 1973; 30: 1010-14.
54. Johnson RE, Tuchler RJ. Role of the pharmacist in primary health care. Am J Hosp Pharm 1975; 32: 162-4.
55. Ivey MF. The pharmacist in the care of the ambulatory mental health patient. Am J Hosp Pharm 1973; 30: 599-606.
56. Reinders TP, Steinke WE. Pharmacist management of anticoagulant therapy in ambulant patients. Am J Hosp Pharm 1979; 36: 645-8.
57. Pegg M, Bourne J, Mackay AD, Lawton WA, Cole RB. The role of the pharmacist in the anticoagulant clinic. J R Coll Physcians Lon 1985; 19: 39-44.
58. Conlan MF. Pharmacist prescribing. Drug Topics 1997; 141: 62-64, 67.
59. Ellenor GL, Dishman BR. Pharmaceutical care role model in psychiatry-pharmacist prescribing. Hosp Pharm 1995; 30: 371-3, 377-8.
60. Szeto J, Brown G. Impact of collaborative drug therapy management by pharmacist [1]. Can J Hosp Pharm 2002; 55: 333-6.
61. Thompson CA. Physician leaders hear details on pharmacist collaborative drug therapy management. Am J Health Syst Pharm 2001; 58: 843, 846.
62. Adams GW. Parenteral nutrition collaborative drug therapy management service. Hosp Pharm 2000; 35: 1242-8.
63. Koch KE. Trends in collaborative drug therapy management. Drug Benefit Trends 2000; 12: 45-54.
64. Reichert SL. Developing a protocol for collaborative drug therapy management. Am J Health Syst Pharm 1999; 56: 1715-7.
65. Landis NT. Panelists describe collaborative drug therapy management efforts. Am J Health Syst Pharm 1996; 53: 501-2, 505-6.
66. Downing D. Pharmaceutical care in emergency contraception. J Am Pharm Assoc 2002; 42 (suppl. 1): S38-S39.
67. Eng HJ. The pharmacist as prescriber. J Clin Pharm Ther 1987; 2: 237-42.
68. Dydek GJ, Blue PW, McKinstry ER. Prescribing and administering privileges for nuclear pharmacists. Am J Hosp Pharm 1988; 45: 792.
69. Covington TR. Toward a rational approach to the issue of prescribing authority for pharmacists. Drug Intell Clin Pharm 1983; 17: 660-6.
70. Flanagan ME. Update on state prescribing authority. Am Pharm 1995; NS35(10): 12-18.
71. Martin JK Jr, Norwood MB. Pharmacist management of antiemetic therapy under protocol in an oncology clinic. Am J Hosp Pharm 1998; 45: 1332-8.
72. Ament PW, McGuire WM. Setting up an automatic pharmacist-initiated pharmacokinetic dosing service. Hosp Form 1993; 28: 589-92.
73. Conte RR. Training and activities of pharmacist prescribers in a California pilot project. Am J Hosp Pharm 1986; 43: 375-80.
74. Doering PL. Pharmacists as prescribers: the Florida experience. Drug Intell Clin Pharm 1986; 20: 983-4.
75. Ferro LA, Marconi RE, Garrelts L, Bennett MS, Boyd EE, Eddinger L, et al. Collaborative practice agreements between pharmacists and physicians. J Am Pharm Assoc 1998; 38: 655-64.
76. Church RM. Pharmacy practice in the Indian health service. Am J Hosp Pharm 1987; 44: 771-5.
77. Cheung A, Sleight SM, Sisson NM. Pharmacy in the veterans administration. Am J Hosp Pharm 1987; 44: 747-54.
78. Cammarta FA, Severson RW, Hiner WO, Gill AW, Hillberg GO, McAuley RJ, et al. Pharmacy practice in the United States army. Am J Hosp Pharm 1987; 44: 755-60.
79. Snook DF, Whiten RE, Holt MR, Barness FR, Tackitt RD. Pharmacy practice in the United States navy. Am J Hosp Pharm 1987; 44: 761-5.
80. Strate RD, Brier KL. Pharmacy practice in the United States air-force. Am J Hosp Pharm 1987; 44: 766-70.
81. Wong EY. Management of acute and chronic pain. Hosp Pharm 1998; 33: 1044-56.
82. Barry CP, Fuller TS. Collaborative drug therapy management: home and hospice care. Hosp Pharm 1998; 33: 797-9, 818.
83. Wong EY, Barry CP. Collaborative drug therapy management: anticoagulation therapy. Hosp Pharm 1998; 33: 1166-71, 1219.
84. Remington H, Jones S. The pharmacist prescriber and a pharmacist-led rheumatology clinic. Pharm J 1999; 263: 500.
85. Still EJ, McPherson G, O'Brien M, Horne R. Investigation of patient satisfaction with pharmacist consultation in a pharmacist-led anticoagulation clinic [abstract]. Pharmacotherapy 1999; 19: 522.
86. Ellinoy BJ, McSherry PV, Rosenthal LC. A pharmacy outpatient monitoring program providing primary medical care to selected patients. Am J Hosp Pharm 1973; 30: 593-8.
87. Taryle DA, Anderson PO. Pharmacist management of ambulatory patients using formalized standards of care. Am J Hosp Pharm 1974; 31: 254-7.
88. Streit RJ. A program expanding the pharmacist's role. J Am Pharm Assoc 1973; NS13: 482-5.
89. Herrier RN, Boyce RW, Apgar DA. Pharmacist-managed patient-care services and prescriptive authority in the U.S. public health service. Hosp Formul 1990; 25: 67-80.
90. Radley AS, Hall J. The establishment and evaluation of a pharmacist-developed anticoagulant clinic. Pharm J 1994; 252: 91-2.
91. Dong BJ, Echaves SA, Brody RV, Shapiro DW. Pharmacist provision of preventive health care service in a hypertension clinic. Am J Health Syst Pharm 1997; 54: 564-6.
92. Horne AL, Dapolite LA. Protocol for pharmacist management of antineoplastic drug-induced adverse effects in outpatients. Am J Health Syst Pharm 1997; 54: 680-3.
93. Morreale AP. Pharmacist-managed helicobacter pylori clinic. Am J Health Syst Pharm 1995; 52: 183-5.
94. Macgregor SH, Hamley JG, Dunbar JA, Dodd TR, Cromarty JA. Evaluation of a primary care anticoagulant clinic managed by a pharmacist. BMJ 1996; 312: 560.
95. Erickson SH. Primary care by a pharmacist in an outpatient clinic. Am J Hosp Pharm 1977; 34: 1086-90.
96. Dong BJ. Pharmacist involvement in a thyroid clinic. Am J Hosp Pharm 1990; 47: 356-61.
97. Brands AJ. Treating ambulatory patients. US Pharm 1977; 2: 70-4.
98. Martin JK. Pharmacist prescriptive authority in the ambulatory oncology clinic. Pharm Pract Manage Q 1995; 15: 34-42.
99. Norton JL. Prescribing warfarin at Overlake Hospital Medical Center. Pharm Pract Manage Q 1995; 15: 17-23.
100. Brennan C. Pharmacist prescribing: Harbourview Medical Center. Pharm Pract Manage Q 1995; 15: 24-30.
101. Williams SE. Outpatient psychiatric prescriptive authority. Pharm Pract Manage Q 1995; 15: 31-3.
102. Cahill RJ. Pharmacist prescribing in a community hospital. Pharm Pract Manage Q 1995; 15: 43-5.
103. Fuller TS. The pharmacist as a prescriber: stories from Washington State - epilogue. Pharm Pract Manage Q 1995; 15: 46-7.
104. Berggren P, Matsuoka R. Pharmacy protocol for adjusting patient-controlled analgesia. Hosp Pharm 1990; 25: 928-9, 932.
105. Barry CP, Fuller TS. Immunization and the pharmacist. Hosp Pharm 1998; 8: 921-5.
106. Reinders TP, Rush DR, Baumgartner RP, Graham AW. Pharmacist's role in management of hypertensive patients in an ambulatory care clinic. Am J Hosp Pharm 1975; 32: 590-4.
107. Coleman JH III, Lee Evans R, Rosenbluth SA. Extended clinical roles for the pharmacist in psychiatric care. Am J Hosp Pharm 1973; 30: 1143-6.
108. Gray M. Pharmacist prescribing: striving for excellence in patient care. Can J Hosp Pharm 2002; 55: 91-2.
109. Spencer JA, Edwards C. Pharmacy beyond the dispensary: general practitioners' views. BMJ 1992; 304: 1670-2.
110. Segal R, Grines LL. Prescribing authority for pharmacists as viewed by organized pharmacy, organized medicine, and the pharmaceutical industry. Drug Intell Clin Pharm 1988; 22: 241-6.